Glucagon-like peptide-1 receptor agonist exenatide has no acute effect on MRI-measured exocrine pancreatic function in patients with type 2 diabetes: a randomized trial
about
Glucagon-like peptide-1 receptor agonist exenatide has no acute effect on MRI-measured exocrine pancreatic function in patients with type 2 diabetes: a randomized trial
description
im Januar 2016 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 13 January 2016
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в січні 2016
@uk
name
Glucagon-like peptide-1 recept ...... 2 diabetes: a randomized trial
@en
Glucagon-like peptide-1 recept ...... 2 diabetes: a randomized trial
@nl
type
label
Glucagon-like peptide-1 recept ...... 2 diabetes: a randomized trial
@en
Glucagon-like peptide-1 recept ...... 2 diabetes: a randomized trial
@nl
prefLabel
Glucagon-like peptide-1 recept ...... 2 diabetes: a randomized trial
@en
Glucagon-like peptide-1 recept ...... 2 diabetes: a randomized trial
@nl
P2093
P356
P1476
Glucagon-like peptide-1 recept ...... 2 diabetes: a randomized trial
@en
P2093
D H van Raalte
I C Pieters-van den Bos
L Tonneijck
M H A Muskiet
M H H Kramer
P304
P356
10.1111/DOM.12612
P50
P577
2016-01-13T00:00:00Z